Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Mol Genet Metab. 2011 May 6;103(4):307–314. doi: 10.1016/j.ymgme.2011.04.016

Table 2. Subjects who did not complete the study.

Groups

Reason Control Months on
Study
Nitisinone Months on
Study
Atrial Fibrillation 1 0.5
Second hip
replacement
1 3 1 12
Corneal damage 1 2
Elevated
transaminases
1 28
Personal 2 16, 24